ACCC offers the latest multidisciplinary education and resources that aim to improve the quality of skin cancer care. With more than 3 million Americans diagnosed with non-melanoma skin cancers each year, skin cancer in the U.S. is on the rise. This may be due to a combination of factors including heightened awareness and screening, better detection, increased longevity, and more sun exposure.
Non-melanoma skin cancers, including basal cell and squamous cell carcinomas which represent 80 percent of skin cancers, are curable when detected early and treated appropriately.
Although far less common, melanoma is much more likely to metastasize. While only one percent of skin cancers are melanomas, this type of cancer is responsible for most skin cancer deaths.
One of the most important things that health care providers can do for patients with non-melanoma skin cancer is coordinate treatment. Multidisciplinary teams in non-melanoma skin cancer care can help determine the best care plan for each patient and improve the quality of care.
In recognition of May as skin cancer awareness month, a disease that affects one in five Americans by 70 years of age, ACCC has developed new resources to support advanced skin cancer care.
May is Skin Cancer Awareness Month! Learn how the Cancer Support Community's patient guides help patient health literacy and promote shared decision-making.
For detailed information about planning a skin cancer screening, download the Academy’s Plan an Event Toolkit at www.SpotSkinCancer.org.
Early diagnosis and timely referral to oncology are crucial for patients with advanced non-melanoma skin cancer to improve their clinical outcomes, treatment opportunities, and quality of life. Learn about the key role dermatologists play in the referral process and how to foster strong relationships between oncologists and dermatologists.
ACCC conducted a series of virtual workshops to engage members of the multidisciplinary care team on effective practices for supporting, treating, and managing patients with advanced cutaneous non-melanoma skin cancers.
Though the incidence of AIDS-defining cancers has decreased with the use of antiretroviral therapy, numerous studies suggest that non-AIDS-defining cancers (cancers not previously associated with HIV and AIDS) appear to be increasing in incidence.
